Acyclovir

Revision as of 01:52, 20 March 2026 by Danbot (talk | contribs) (Replace manual dosing with dynamic SMW tables (Adult + Pediatric))

General

Adult Dosing

Indications by Disease

DiseaseDoseContext
Bell's palsy400mg 5x per day x1 weekAntiviral
Encephalitis10mg/kg (10-15mg/kg for pediatrics) every 8hrsHSV
Herpes Simplex Virus-2400mg PO q8hrs x 7-10 days or 200mg PO 5x/day x 7-10 daysInitial Episode
Herpes Simplex Virus-2400mg PO q8hrs x 5 days or 800mg PO q12hrs x 5 days or 800mg PO q8hrs x 2 daysRecurrence
Herpes Simplex Virus-2400mg PO q12hrs dailySuppressive
Herpes gingivostomatitis400 mg PO 5x/day (q4hrs while awake) x 5 daysNormal host
Herpes gingivostomatitis5 mg/kg IV q8h x 7 daysImmunocompromised
Herpes gingivostomatitis400mg PO 5x/day x 14-21 daysImmunocompromised (oral)
Herpes labialis400 mg PO 5x/day (q4hrs while awake) x 5 daysNormal host
Herpes labialis5 mg/kg IV q8h x 7 daysImmunocompromised
Herpes labialis400mg PO 5x/day x 14-21 daysImmunocompromised (oral)

Pediatric Dosing

Indications by Disease

DiseaseDoseContext
Encephalitis20mg/kg IV q8hrs x 21 days (neonates); 10-15mg/kg IV q8hrs x 14-21 days (children)Pediatric HSV
Herpes gingivostomatitis40-80mg/kg PO divided in 3-4 doses for 5-7 daysNormal host
Herpes labialis40-80mg/kg PO divided in 3-4 doses for 5-7 daysNormal host
Neonatal conjunctivitis20mg/kg IV q8h x 14-21 daysHerpetic conjunctivitis
Pediatric fever of uncertain source20mg/kg/doseNeonatal 0-28 days if HSV suspected

Special Populations

  • Pregnancy Rating: B
  • Lactation Risk Categories: Safe
  • Renal Dosing
    • Adult
      • IV
        • CrCl 25-50 give q12h
        • CrCl 10-24 give q24h
        • CrCl <10 decrease dose 50%, give q24h
        • HD give usual dose as supplement
        • PD no supplement
      • PO
        • CrCl <25: see package insert
        • HD: give usual dose as supplement
        • PD: no supplement
    • Pediatric
    • Geriatric
      • Refer to adult dosing. Oral: Initial doses should begin at the low end of the dosage range
  • Hepatic Dosing
    • Not defined

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

  • Nausea/vomiting/diarrhea
  • Headache
  • Dizziness
  • Rash
  • Arthralgia
  • Confusion / lethargy
  • Elev. BUN/creatinine
  • Photosensitivity

Pharmacology

  • Half-life: 2.5 - 3.3 hrs
  • Metabolism: virally infected cells (intracellularly); liver
  • Excretion: Urine
  • Mechanism of Action: Inhibits DNA polymerase

See Also

References

  • Epocrates 2015
  • Acetazolamide injection [prescribing information]. Big Flats, NY: X-Gen Pharmaceuticals, Inc; October 2015.
  • Acetazolamide tablets [prescribing information]. Hawthorne, NY: Taro Pharmaceuticals; September 2013.